| Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial S Ali, SM Uddin, E Shalim, MA Sayeed, F Anjum, F Saleem, ... EClinicalMedicine 36, 2021 | 57 | 2021 |
| Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma S Ali, SM Uddin, A Ali, F Anjum, R Ali, E Shalim, M Khan, I Ahmed, ... Immunotherapy 13 (5), 397-407, 2021 | 32 | 2021 |
| Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a … S Ali, S Luxmi, F Anjum, SM Muhaymin, SM Uddin, A Ali, MR Ali, ... Trials 21, 1-3, 2020 | 15 | 2020 |
| Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial. EClinicalMedicine. 2021; 36: 100926 S Ali, SM Uddin, E Shalim | 5 | 2021 |
| Comparison of the Disease Severity and Outcome of Vaccinated COVID-19 Patients with Unvaccinated Patients in a Specialized COVID-19 Facility: A Retrospective Cohort Study from … MA Sayeed, E Shalim, F Farooqui, S Farman, M Khan, A Iqbal, I Ahmed, ... Vaccines 11 (7), 1178, 2023 | 4 | 2023 |
| Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial S Ali, E Shalim, F Farhan, F Anjum, A Ali, SM Uddin, F Shahab, M Haider, ... Trials 23 (1), 932, 2022 | 1 | 2022 |
| Risk Factors and Outcome of Acute Kidney Injury in Critical COVID-19 patients in Karachi, Pakistan: A Single center, Retrospective study A Haider, E Shalim, S Afzal Pakistan Journal of Kidney Diseases 7 (2), 3-7, 2023 | | 2023 |
